Abstract
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used for refractory cardiogenic shock and is still associated with frequent morbidities and high mortality. Many risk scores have been used to stratify the patients for rapid decision making. The recent studies using the risk scores during VA-ECMO support were reviewed and the conflicting results were addressed. The Survival After VA-ECMO (SAVE), modified SAVE, Sequential Organ Failure Assessment (SOFA), Simplified Acute Physiology score II (SAPS II), REMEMBER, ENCOURAGE scores were used in retrospective studies without validation prospective studies. The risk scores used in evaluation of adult patients with VA-ECMO support for refractory cardiogenic shock help in clinical judgment but should not affect decision making for withdrawal of support.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.